{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:34:26Z","timestamp":1790033666330,"version":"4.0.1"},"reference-count":87,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The Epstein-Barr virus (EBV) belongs to the gamma herpesviruses family. Evidence from the literature suggests that EBV initiates immune responses and the production of antibodies. Chronic or recurrent EBV infections may be associated with autoimmune diseases such as systemic lupus erythematosus, Sj\u00f6gren\u2019s syndrome, rheumatoid arthritis, multiple sclerosis, or inflammatory bowel diseases. This review aims to establish the role of EBV in the development and progression of autoimmune diseases. Materials and Methods: A literature search was conducted using PubMed, PMC, Google Scholar, and SCOPUS. Relevant studies, including meta-analyses, case-control studies, literature reviews, cross-sectional studies, and longitudinal studies, were identified through titles and abstracts screening for a comprehensive analysis. Results: Our study revealed a strong association between EBV infection and several autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease. Epstein-Barr virus seropositivity was significantly higher in affected individuals. Elevated EBV-specific antibodies correlated with disease onset and severity. EBV DNA and latency proteins were detected in diseased tissues, alongside immune dysregulation and molecular mimicry mechanisms. Conclusions: Our findings highlight that EBV may be an important factor in autoimmune disease pathogenesis, contributing to immune activation and tissue damage. Further research is needed to explore EBV-targeted therapies and their potential in preventing or managing autoimmune diseases.<\/jats:p>","DOI":"10.3390\/medicina61071148","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T03:39:59Z","timestamp":1750909199000},"page":"1148","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of Epstein-Barr Virus in the Pathogenesis of Autoimmune Diseases"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-3880","authenticated-orcid":false,"given":"Natalia","family":"Morawiec","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-5350","authenticated-orcid":false,"given":"Bo\u017cena","family":"Adamczyk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2288-6411","authenticated-orcid":false,"given":"Aleksandra","family":"Spyra","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-261X","authenticated-orcid":false,"given":"Miko\u0142aj","family":"Herba","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1947-4594","authenticated-orcid":false,"given":"Sylwia","family":"Boczek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Korbel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Polecho\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6894-9891","authenticated-orcid":false,"given":"Monika","family":"Adamczyk-Sowa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 3 Maja 13-15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/microbiolspec.DMIH2-0011-2015","article-title":"Epstein-Barr Virus","volume":"4","author":"Nowalk","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Houen, G., and Trier, N.H. (2021). Epstein-Barr Virus and Systemic Autoimmune Diseases. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.587380"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein\u2013Barr Virus Infection and Posttransplant Lymphoproliferative Disorder","volume":"13","author":"Green","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_4","first-page":"1","article-title":"Epstein\u2013Barr virus as a leading cause of multiple sclerosis: Mechanisms and implications","volume":"19","author":"Bjornevik","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhang, H., Zhao, S., and Cao, Z. (2022). Impact of Epstein\u2013Barr virus infection in patients with inflammatory bowel disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1001055"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Smatti, M.K., Al-Sadeq, D.W., Ali, N.H., Pintus, G., Abou-Saleh, H., and Nasrallah, G.K. (2018). Epstein\u2013Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00211"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41467-022-29307-3","article-title":"Identification of host\u2013pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank","volume":"13","author":"Mentzer","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kuri, A., Jacobs, B.M., Vickaryous, N., Pakpoor, J., Middeldorp, J., Giovannoni, G., and Dobson, R. (2020). Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09049-x"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"010404","DOI":"10.7189\/jogh.10.010404","article-title":"Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature","volume":"10","author":"Winter","year":"2020","journal-title":"J. Glob. Health"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., and Yamanishi, K. (2007). The epidemiology of EBV and its association with malignant disease. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge University Press.","DOI":"10.1017\/CBO9780511545313"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chen, M.-R. (2011). Epstein\u2013Barr Virus, the Immune System, and Associated Diseases. Front. Microbiol., 2.","DOI":"10.3389\/fmicb.2011.00005"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"M\u00fcnz, C. (2015). Infectious Mononucleosis. Epstein Barr Virus Volume 1, Springer International Publishing.","DOI":"10.1007\/978-3-319-22822-8"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, Virologic, and Immunologic Factors Associated with Acquisition and Severity of Primary Epstein\u2013Barr Virus Infection in University Students","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1038\/emm.2014.109","article-title":"EBV and human cancer","volume":"47","author":"Ko","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/sjg.SJG_30_20","article-title":"Clinical features of Epstein\u2013Barr virus in the intestinal mucosa and blood of patients with inflammatory bowel disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cai, J., Zhang, B., Li, Y., Zhu, W., Akihisa, T., Li, W., Kikuchi, T., Liu, W., Feng, F., and Zhang, J. (2021). Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction. Vaccines, 9.","DOI":"10.3390\/vaccines9111290"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Abusalah, M.A.H., Gan, S.H., Al-Hatamleh, M.A.I., Irekeola, A.A., Shueb, R.H., and Yean Yean, C. (2020). Recent Advances in Diagnostic Approaches for Epstein\u2013Barr Virus. Pathogens, 9.","DOI":"10.3390\/pathogens9030226"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365513.2018.1550807","article-title":"Increased antibody levels to stage-specific Epstein\u2013Barr virus antigens in systemic autoimmune diseases reveal a common pathology","volume":"79","author":"Draborg","year":"2019","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jog, N.R., and James, J.A. (2021). Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.623944"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1158\/1078-0432.CCR-22-1600","article-title":"Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma","volume":"28","author":"Paudel","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"29595","DOI":"10.1002\/jmv.29595","article-title":"Evaluation of serum Epstein\u2013Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases","volume":"96","author":"Li","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Takei, M., Kitamura, N., Nagasawa, Y., Tsuzuki, H., Iwata, M., Nagatsuka, Y., Nakamura, H., Imai, K., and Fujiwara, S. (2022). Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein\u2013Barr Virus. Viruses, 14.","DOI":"10.3390\/v14091900"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fran\u00e7a, S.A.d.S., Viana, J.B.G.d.O., G\u00f3es, H.C.A., Fonseca, R.R.d.S., Laurentino, R.V., Costa, I.B., Oliviera-Fihlo, A.B., and Machado, L.F.A. (2022). Epidemiology of the Epstein\u2013Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil. Viruses, 14.","DOI":"10.3390\/v14040694"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Silva, J.d.M., Alves, C.E.d.C., and Pontes, G.S. (2024). Epstein-Barr virus: The mastermind of immune chaos. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1297994"},{"key":"ref_26","first-page":"327","article-title":"Epstein-Barr virus and autoimmunity: Effective preventive and therapeutic strategies are urgently needed","volume":"61","author":"Rzymski","year":"2023","journal-title":"Rheumatology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"SoRelle, E.D., Reinoso-Vizcaino, N.M., Horn, G.Q., and Luftig, M.A. (2022). Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1001145"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e28363","DOI":"10.1002\/jmv.28363","article-title":"A common mechanism links Epstein-Barr virus infections and autoimmune diseases","volume":"95","author":"Zhang","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1182\/blood-2006-05-021303","article-title":"Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth","volume":"108","author":"Tobollik","year":"2006","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"70016","DOI":"10.1111\/sji.70016","article-title":"The Role of Epstein\u2013Barr Virus Molecular Mimicry in Various Autoimmune Diseases","volume":"101","author":"Munir","year":"2025","journal-title":"Scand. J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.imlet.2023.07.006","article-title":"Epstein\u2013Barr virus and genetic risk variants as determinants of T-bet+ B cell-driven autoimmune diseases","volume":"261","author":"Bogers","year":"2023","journal-title":"Immunol. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gugliesi, F., Pasquero, S., Griffante, G., Scutera, S., Albano, C., Pacheco, S.F.C., Riva, G., Dell\u2019Oste, V., and Biolatti, M. (2021). Human Cytomegalovirus and Autoimmune Diseases: Where Are We?. Viruses, 13.","DOI":"10.3390\/v13020260"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1038\/s41467-024-53658-8","article-title":"Molecular mimicry as a mechanism of viral immune evasion and autoimmunity","volume":"15","author":"Maguire","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ebrahimi, F., Rasizadeh, R., Sharaflou, S., Aghbash, P.S., Shamekh, A., Jafari-Sales, A., and Baghi, H.B. (2024). Coinfection of EBV with other pathogens: A narrative review. Front. Virol., 4.","DOI":"10.3389\/fviro.2024.1482329"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/s41467-025-60276-5","article-title":"Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes","volume":"16","author":"Higdon","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41582-025-01099-2","article-title":"Genetic susceptibility determines Epstein\u2013Barr-virus-associated risk of multiple sclerosis","volume":"21","author":"Kiani","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e2420070121","DOI":"10.1073\/pnas.2420070121","article-title":"Connecting the dots: Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of multiple sclerosis","volume":"121","author":"Lanz","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar1893","article-title":"Epstein\u2013Barr virus and rheumatoid arthritis: Is there a link?","volume":"8","author":"Costenbader","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1016\/j.cell.2024.08.025","article-title":"Neoself-antigens are the primary target for autoreactive T cells in human lupus","volume":"187","author":"Mori","year":"2024","journal-title":"Cell"},{"key":"ref_40","unstructured":"McDowell, C., Farooq, U., and Haseeb, M. (2025). Inflammatory Bowel Disease. StatPearls, StatPearls Publishing."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2025.01.247","article-title":"Epstein-Barr Virus Exposure Precedes Crohn\u2019s Disease Development","volume":"169","author":"Nandy","year":"2025","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cgh.2020.02.009","article-title":"Predicting, Preventing, and Managing Treatment-Related Complications in Patients with Inflammatory Bowel Diseases","volume":"18","author":"Beaugerie","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1053\/j.gastro.2017.02.004","article-title":"Infliximab Is Not Associated with Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients with Inflammatory Bowel Disease","volume":"152","author":"Hyams","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MEG.0000000000002505","article-title":"Infectious mononucleosis is associated with an increased incidence of Crohn\u2019s disease: Results from a cohort study of 31 862 outpatients in Germany","volume":"35","author":"Loosen","year":"2023","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2249.1994.tb06525.x","article-title":"Antibody reactivity to an Epstein\u2013Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 \u03b2 chain","volume":"95","author":"Parkkonen","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1586\/eci.10.91","article-title":"Protection against or triggering of Type 1 diabetes? Different roles for viral infections","volume":"7","author":"Boettler","year":"2011","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, S.-C., and Liao, J.-Y. (2022). Epidemiologic Implication of the Association between Herpes Simplex Virus Infection and the Risk of Type 1 Diabetes Mellitus: A Nationwide Case-Control Study in Taiwan. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19137832"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.22578\/IJMS.17.3-4.3","article-title":"The possible Association between Epstein-Barr Virus and Type 1 Diabetes Mellitus","volume":"17","author":"Mohammed","year":"2019","journal-title":"Iraqi J. Med. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Chen, X.-Y., Wang, C., Chen, S., Tian, M., Wang, X., and Zhang, L. (2022). Fulminant Type 1 Diabetes Mellitus Associated with Drug Hypersensitivity and Epstein\u2013Barr Virus Infection: A Case Report. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.884878"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/jdi.13091","article-title":"Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research","volume":"10","author":"Hosokawa","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102781","DOI":"10.1016\/j.jaut.2021.102781","article-title":"Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus","volume":"127","author":"Afrasiabi","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Laurynenka, V., Ding, L., Kaufman, K.M., James, J.A., and Harley, J.B. (2022). A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.830993"},{"key":"ref_54","first-page":"121","article-title":"INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS","volume":"338","author":"Guta","year":"2023","journal-title":"Georgian Med. News"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Banko, A., Cirkovic, A., Miskovic, R., Jeremic, I., Grk, M., Basaric, M., Lazarevic, I., Raskovic, S., Despotovic, A., and Miljanovic, D. (2023). Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1307589"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","article-title":"Weisman, M.H.; Karp, D.R.; et al. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals","volume":"78","author":"Jog","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/0961203320940029","article-title":"Epstein\u2013Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: Correlation with clinical and laboratory indices of disease activity","volume":"29","author":"Aygun","year":"2020","journal-title":"Lupus"},{"key":"ref_58","first-page":"230","article-title":"Overall Status of Epstein-Barr Virus Infection, IFN-a, and TLR-7\/9 in Patients with Systemic Lupus Erythematous","volume":"18","author":"Izadi","year":"2021","journal-title":"Iran. J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s10067-024-06917-4","article-title":"A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus","volume":"43","author":"Chen","year":"2024","journal-title":"Clin. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10067-022-06369-8","article-title":"Clinical characteristics of SLE patients infected with Epstein-Barr virus and potential associated risk factors","volume":"42","author":"Ming","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/09612033211010339","article-title":"EBV load is associated with cfDNA fragmentation and renal damage in SLE patients","volume":"30","author":"Truszewska","year":"2021","journal-title":"Lupus"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"156227","DOI":"10.1016\/j.cyto.2023.156227","article-title":"Chronic Epstein-Barr virus infection: A potential junction between primary Sj\u00f6gren\u2019s syndrome and lymphoma","volume":"168","author":"Yang","year":"2023","journal-title":"Cytokine"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Barcelos, F., Martins, C., Monteiro, R., Cardigos, J., Prussiani, T., S\u00edtima, M., Alves, N., Vaz-Patto, J., Cunha-Branco, J., and Borrego, L.-M. (2021). Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-83550-0"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Xuan, J., Ji, Z., Wang, B., Zeng, X., Chen, R., He, Y., Rao, P., Wu, P., and Shi, G. (2020). Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sj\u00f6gren\u2019s Syndrome. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.590444"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/jop.13036","article-title":"EBV and CMV viral load in rheumatoid arthritis and their role in associated Sj\u00f6gren\u2019s syndrome","volume":"49","author":"Sorgato","year":"2020","journal-title":"J. Oral Pathol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Munir, A., Khan, S., Khan, S., Attaullah, S., Munir, M., Saleem, A., and Ali, I. (2023). Frequency and association of Epstein-Barr Virus genotype in rheumatoid arthritis patients of Khyber Pakhtunkhwa, Pakistan. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0295124"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"19141","DOI":"10.1002\/jcp.28641","article-title":"Thyroid autoimmune diseases and thyroid tumors: Would EBV infection be the link?","volume":"234","author":"Ward","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Hamad, M.N., Mohamed, F.I., Osman, M.M., Jadid, A.A., Abdalrhman, I.K., Yousif, A.M., Alabid, T., Edris, A.M.M., Mohamed, N.S., and Siddig, E.E. (2023). Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto\u2019s thyroiditis. BMC Res. Notes, 16.","DOI":"10.1186\/s13104-023-06399-8"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B., Ludian, J., Kiszczak-Bochy\u0144ska, E., Smole\u0144, A., Roli\u0144ski, J., and Pyzik, D. (2019). Does the Epstein\u2013Barr Virus Play a Role in the Pathogenesis of Graves\u2019 Disease?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133145"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/25785826.2019.1701365","article-title":"An eight-year-old girl with autoimmune polyglandular syndrome type3A that developed during the course of primary Epstein\u2013Barr virus (EBV) infection: Clinical implication of EBV in autoimmune thyroid disease","volume":"43","author":"Kirino","year":"2020","journal-title":"Immunol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/vim.2019.0086","article-title":"Subclinical Epstein-Barr Virus Primary Infection and Lytic Reactivation Induce Thyrotropin Receptor Autoantibodies","volume":"32","author":"Tamoto","year":"2019","journal-title":"Viral Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1507\/endocrj.EJ22-0609","article-title":"Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves\u2019 disease","volume":"70","author":"Nagata","year":"2023","journal-title":"Endocr. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased Toll-Like Receptor 4 Expression in Thymus of Myasthenic Patients with Thymitis and Thymic Involution","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","article-title":"Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein\u2013Barr virus infection","volume":"221","author":"Cavalcante","year":"2016","journal-title":"Immunobiology"},{"key":"ref_75","first-page":"385","article-title":"Epstein-Barr Virus Genome in Thymoma and Thymic Lymphoid Hyperplasia","volume":"131","author":"Mcguire","year":"1988","journal-title":"Am. J. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nyas.13534","article-title":"Toll-like receptors 7 and 9 in myasthenia gravis thymus: Amplifiers of autoimmunity?","volume":"1413","author":"Cavalcante","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Zachova, K., Kosztyu, P., Zadrazil, J., Matousovic, K., Vondrak, K., Hubacek, P., Julian, B.A., Moldoveanu, Z., Novak, Z., and Kostovicikova, K. (2020). Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00267"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mestecky, J., Julian, B.A., and Raska, M. (2023). IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1085922"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s13730-019-00409-0","article-title":"Acute kidney injury in an adult patient with IgA nephropathy and chronic replicative Epstein\u2013Barr virus infection","volume":"8","author":"Sato","year":"2019","journal-title":"CEN Case Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/1352458520907901","article-title":"Systematic review and meta-analysis of the association between Epstein\u2013Barr virus, multiple sclerosis and other risk factors","volume":"26","author":"Jacobs","year":"2020","journal-title":"Mult. Scler. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00415-020-10119-8","article-title":"An atlas on risk factors for multiple sclerosis: A Mendelian randomization study","volume":"268","author":"Yuan","year":"2021","journal-title":"J. Neurol."},{"key":"ref_82","first-page":"166","article-title":"Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review","volume":"20","author":"Maroufi","year":"2021","journal-title":"Curr. J. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"691","DOI":"10.36740\/WLek202203122","article-title":"THE POTENTIAL ROLE OF EPSTEIN BARR VIRUS IN MULTIPLE SCLEROSIS MOLECULAR AND SEROLOGICAL STUDY","volume":"75","author":"Ali","year":"2022","journal-title":"Wiad. Lek."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2500\/aap.2024.45.240070","article-title":"Immunodeficiency: Overview of primary immune regulatory disorders (PIRDs)","volume":"45","author":"Nelson","year":"2024","journal-title":"Allergy Asthma Proc."},{"key":"ref_86","unstructured":"(2025, June 19). ClinicalTrials.gov n.d, Available online: https:\/\/clinicaltrials.gov."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Cui, X., and Snapper, C.M. (2021). Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.734471"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1148\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:58:36Z","timestamp":1760032716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":87,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071148"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071148","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}